Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

medicalnewstoday.com

1 of 0

Resource Description:

Additional beneficial effects on 'cardiometabolic risk factors' beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an a

« Back to the Effects of Obesity Drugs WisdomCard

Related Health Centers:

Advertisement